Uchida, A., Isobe, Y., Asano, J., Uemura, Y., Hoshikawa, M., Takagi, M. and Miura, I. (2019) “Targeting BCL2 with venetoclax is a promising therapeutic strategy for ‘double-proteinexpression’ lymphoma with MYC and BCL2 rearrangements”, Haematologica. Pavia, Italy, 104(7), pp. 1417-1421. doi: 10.3324/haematol.2018.204958.